Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 41427-41428 [2013-16433]
Download as PDF
<![CDATA[
TKELLEY on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 132 / Wednesday, July 10, 2013 / Notices
allows the participant (or its counsel or
representative) to digitally sign
documents and access the E-Submittal
server for any proceeding in which it is
participating; and (2) advise the
Secretary that the participant will be
submitting a request or petition for
hearing (even in instances in which the
participant, or its counsel or
representative, already holds an NRCissued digital certificate). Based on this
information, the Secretary will establish
an electronic docket for the hearing in
this proceeding if the Secretary has not
already established an electronic docket.
Information about applying for a
digital ID certificate is available on the
NRC’s public Web site at https://
www.nrc.gov/site-help/e-submittals/
apply-certificates.html. System
requirements for accessing the
E-Submittal server are detailed in the
NRC’s ‘‘Guidance for Electronic
Submission,’’ which is available on the
NRC’s public Web site at https://
www.nrc.gov/site-help/
e-submittals.html. Participants may
attempt to use other software not listed
on the Web site, but should note that the
NRC’s E-Filing system does not support
unlisted software, and the NRC Meta
System Help Desk will not be able to
offer assistance in using unlisted
software.
If a participant is electronically
submitting a document to the NRC in
accordance with the E-Filing rule, the
participant must file the document
using the NRC’s online, Web-based
submission form. In order to serve
documents through the Electronic
Information Exchange System, users
will be required to install a Web
browser plug-in from the NRC’s Web
site. Further information on the Webbased submission form, including the
installation of the Web browser plug-in,
is available on the NRC’s public Web
site at https://www.nrc.gov/site-help/
e-submittals.html.
Once a participant has obtained a
digital ID certificate and a docket has
been created, the participant can then
submit a request for a hearing or
petition for leave to intervene.
Submissions should be in Portable
Document Format (PDF) in accordance
with the NRC guidance available on the
NRC’s public Web site at https://www.
nrc.gov/site-help/e-submittals.html. A
filing is considered complete at the time
the documents are submitted through
the NRC’s E-filing system. To be timely,
an electronic filing must be submitted to
the E-Filing system no later than 11:59
p.m. Eastern Time on the due date.
Upon receipt of a transmission, the EFiling system time-stamps the document
and sends the submitter an email notice
VerDate Mar<15>2010
17:42 Jul 09, 2013
Jkt 229001
confirming receipt of the document. The
E-Filing system also distributes an email
notice that provides access to the
document to the NRC’s Office of the
General Counsel and any others who
have advised the Office of the Secretary
that they wish to participate in the
proceeding, so that the filer need not
serve the document on those
participants separately. Therefore,
applicants and other participants (or
their counsel or representative) must
apply for and receive a digital ID
certificate before a hearing request/
petition to intervene is filed so that they
may obtain access to the document via
the E-Filing system.
A person filing electronically using
the NRC’s adjudicatory E-Filing system
may seek assistance by contacting the
NRC Meta System Help Desk through
the ‘‘Contact Us’’ link located on the
NRC Web site at https://www.nrc.gov/
site-help/e-submittals.html, by email to
MSHD.Resource@nrc.gov, or by a tollfree call to 1–866–672–7640. The NRC
Meta System Help Desk is available
between 9 a.m. and 7 p.m., Eastern
Time, Monday through Friday,
excluding government holidays.
Participants who believe that they
have good cause for not submitting
documents electronically must file an
extension request, in accordance with
10 CFR 2.302(g), with their initial paper
filing requesting authorization to
continue to submit documents in paper
format. Such filings must be submitted
by (1) first class mail addressed to the
Office of the Secretary of the
Commission, U.S. Nuclear Regulatory
Commission, Washington, DC 20555–
0001, Attention: Rulemaking and
Adjudications Staff; or (2) courier,
express mail, or expedited delivery
service to the Office of the Secretary,
Sixteenth Floor, One White Flint North,
11555 Rockville Pike, Rockville,
Maryland 20852, Attention: Rulemaking
and Adjudications Staff. Participants
filing a document in this manner are
responsible for serving the document on
all other participants. Copies shall be
sent to the Director, Office of
Enforcement and the Assistant General
Counsel for Materials Litigation and
Enforcement at the same address, the
Regional Administrator, NRC Region II,
Marquis One Tower, Suite 1200, 245
Peachtree Center Avenue NE., Atlanta,
GA 30303, and to the Licensee, Duke
Energy Carolinas, LLC, Oconee Nuclear
Station, 7800 Rochester Highway,
Seneca, SC 29672. Filing is considered
complete by first-class mail as of the
time of deposit in the mail, or by
courier, express mail, or expedited
delivery service upon depositing the
document with the provider of the
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
41427
service. A presiding officer, having
granted an exemption request from
using E-Filing, may require a participant
or party use E-Filing if the presiding
officer subsequently determines that the
reason for granting the exemption from
use of E-Filing no longer exists.
Documents submitted in adjudicatory
proceedings will appear in NRC’s
electronic hearing docket, which is
available to the public at https://
ehd1.nrc.gov/ehd, unless excluded
pursuant to an Order of the
Commission, an Atomic Safety and
Licensing Board, or the presiding
officer. Participants are requested not to
include personal privacy information,
such as social security numbers, home
addresses, or home phone numbers in
their filings, unless an NRC regulation
or other law requires submission of such
information. With respect to
copyrighted works, except for limited
excerpts that serve the purpose of the
adjudicatory filings and would
constitute a Fair Use application,
participants are requested not to include
copyrighted materials in their
submissions.
If a person other than the licensee
requests a hearing, that person shall set
forth with particularity the manner in
which his or her interest is adversely
affected by this Order and shall address
the criteria set forth in 10 CFR 2.309(d)
and (f).
In the absence of any request for
hearing or written approval of an
extension of time in which to request a
hearing, the provisions specified in
Section IV above shall be final 30 days
from the date of this Order without
further order or proceedings. If an
extension of time for requesting a
hearing has been approved, the
provisions specified in Section IV shall
be final when the extension expires if a
hearing request has not been received.
Dated this 1st day of July 2013.
For the Nuclear Regulatory Commission.
Roy Zimmerman,
Director, Office of Enforcement.
[FR Doc. 2013–16588 Filed 7–9–13; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
Advisory Committee on the Medical
Uses of Isotopes: Meeting Notice
U.S. Nuclear Regulatory
Commission.
ACTION: Notice of meeting.
AGENCY:
NRC will convene a meeting
of the Advisory Committee on the
Medical Uses of Isotopes (ACMUI) on
SUMMARY:
E:\FR\FM\10JYN1.SGM
10JYN1
41428
Federal Register / Vol. 78, No. 132 / Wednesday, July 10, 2013 / Notices
September 9–10, 2013. A sample of
agenda items to be discussed during the
public session includes: (1) An update
on the 10 CFR Part 35 Rulemaking; (2)
a discussion on the development of 10
CFR 35.1000 Guidance; (3) a discussion
on the ACMUI reporting structure; (4)
permanent implant brachytherapy
guidance; (5) the Medical Events
Subcommittee Report. The agenda is
subject to change. The current agenda
and any updates will be available at
https://www.nrc.gov/reading-rm/doccollections/acmui/meetings/2013.html
or by emailing Ms. Sophie Holiday at
the CONTACT INFORMATION below.
Purpose: Discuss issues related to 10
CFR part 35 Medical Use of Byproduct
Material.
Date and Time for Closed Sessions:
September 09, 2013, from 8:30 a.m. to
10:30 a.m. and September 10, 2013 from
8:30 a.m. to 10:30 a.m. The first session
will be closed for ACMUI training. The
second session will be closed so that
ACMUI members can prepare for a
Commission Briefing in October 2013.
Date and Time for Open Sessions:
September 09, 2013, from 10:30 a.m. to
5:00 p.m. and September 10, 2013, from
10:30 a.m. to 5:00 p.m.
Address for Public Meeting: U.S.
Nuclear Regulatory Commission, Two
White Flint North Building, Room T2–
B3, 11545 Rockville Pike, Rockville, MD
20852.
Public participation: Any member of
the public who wishes to participate in
the meeting in person or via phone
should contact Ms. Holiday using the
information below. The meeting will
also be webcast live: video.nrc.gov.
CONTACT INFORMATION: Sophie J.
Holiday, email: sophie.holiday@nrc.gov,
telephone: (301) 415–7865.
TKELLEY on DSK3SPTVN1PROD with NOTICES
Conduct of the Meeting
Bruce R. Thomadsen, Ph.D., will chair
the meeting. Dr. Thomadsen will
conduct the meeting in a manner that
will facilitate the orderly conduct of
business. The following procedures
apply to public participation in the
meeting:
1. Persons who wish to provide a
written statement should submit an
electronic copy to Ms. Holiday at the
contact information listed above. All
submittals must be received by
September 2, 2013, and must pertain to
the topic on the agenda for the meeting.
2. Questions and comments from
members of the public will be permitted
during the meeting, at the discretion of
the Chairman.
3. The draft transcript and meeting
summary will be available on ACMUI’s
Web site https://www.nrc.gov/reading-
VerDate Mar<15>2010
17:42 Jul 09, 2013
Jkt 229001
rm/doc-collections/acmui/meetings/
2013.html on or about October 22, 2013.
4. Persons who require special
services, such as those for the hearing
impaired, should notify Ms. Holiday of
their planned attendance.
This meeting will be held in
accordance with the Atomic Energy Act
of 1954, as amended (primarily Section
161a); the Federal Advisory Committee
Act (5 U.S.C. App); and the
Commission’s regulations in Title 10,
U.S. Code of Federal Regulations, Part 7.
Dated: July 1, 2013.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2013–16433 Filed 7–9–13; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
[EA–12–193; NRC–2013–0142]
In the Matter of Licensee Identified in
Attachment 1 and All Other Persons
Who Obtain Safeguards Information
Described Herein; Order Imposing
Requirements for the Protection of
Certain Safeguards Information
(Effective Immediately)
I
The Licensee, identified in
Attachment 1 1 to this Order, holds a
license issued in accordance with the
Atomic Energy Act of 1954, as amended,
(AEA) by the U.S. Nuclear Regulatory
Commission (NRC or the Commission)
or an Agreement State, authorizing it to
possess, use, and transfer items
containing radioactive material
quantities of concern. The NRC intends
to issue security Orders to this licensee
in the near future. The Order will
require compliance with specific
Additional Security Measures to
enhance the security for certain
radioactive material quantities of
concern. The Commission has
determined that these documents will
contain Safeguards Information, will not
be released to the public, and must be
protected from unauthorized disclosure.
Therefore, the Commission is imposing
the requirements, as set forth in
Attachments 2 and 3 to this Order and
in Order EA–12–194, so that the
Licensee can receive these documents.
This Order also imposes requirements
for the protection of Safeguards
Information in the hands of any person,2
1 Attachment 1 contains sensitive information
and will not be released to the public.
2 Person means (1) any individual, corporation,
partnership, firm, association, trust, estate, public
or private institution, group, government agency
other than the Commission or the U.S. Department
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
whether or not a licensee of the
Commission, who produces, receives, or
acquires Safeguards Information.
II
The Commission has broad statutory
authority to protect and prohibit the
unauthorized disclosure of Safeguards
Information. Section 147 of the AEA
grants the Commission explicit
authority to ‘‘. . . issue such orders, as
necessary to prohibit the unauthorized
disclosure of safeguards information
. . .’’ This authority extends to
information concerning the security
measures for the physical protection of
special nuclear material, source
material, and byproduct material.
Licensees and all persons who produce,
receive, or acquire Safeguards
Information must ensure proper
handling and protection of Safeguards
Information to avoid unauthorized
disclosure in accordance with the
specific requirements for the protection
of Safeguards Information contained in
Attachments 2 and 3 to this Order. The
Commission hereby provides notice that
it intends to treat violations of the
requirements contained in Attachments
2 and 3 to this Order applicable to the
handling and unauthorized disclosure
of Safeguards Information as serious
breaches of adequate protection of the
public health and safety and the
common defense and security of the
United States.
Access to Safeguards Information is
limited to those persons who have
established the need-to-know the
information, are considered to be
trustworthy and reliable, and meet the
requirements of Order EA–12–194. A
need-to-know means a determination by
a person having responsibility for
protecting Safeguard Information that a
proposed recipient’s access to
Safeguards Information is necessary in
the performance of official, contractual,
or licensee duties of employment.
The Licensee and all other persons
who obtain Safeguards Information
must ensure that they develop, maintain
and implement strict policies and
procedures for the proper handling of
Safeguards Information to prevent
unauthorized disclosure, in accordance
with the requirements in Attachments 2
and 3 to this Order. The Licensee must
ensure that all contractors whose
of Energy, except that the DOE shall be considered
a person with respect to those facilities of the DOE
specified in section 202 of the Energy
Reorganization Act of 1974 (88 Stat. 1244), any
State or any political subdivision of, or any political
entity within a State, any foreign government or
nation or any political subdivision of any such
government or nation, or other entity; and (2) any
legal successor, representative, agent, or agency of
the foregoing.
E:\FR\FM\10JYN1.SGM
10JYN1
]]>Agencies
[Federal Register Volume 78, Number 132 (Wednesday, July 10, 2013)]
[Notices]
[Pages 41427-41428]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-16433]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: NRC will convene a meeting of the Advisory Committee on the
Medical Uses of Isotopes (ACMUI) on
[[Page 41428]]
September 9-10, 2013. A sample of agenda items to be discussed during
the public session includes: (1) An update on the 10 CFR Part 35
Rulemaking; (2) a discussion on the development of 10 CFR 35.1000
Guidance; (3) a discussion on the ACMUI reporting structure; (4)
permanent implant brachytherapy guidance; (5) the Medical Events
Subcommittee Report. The agenda is subject to change. The current
agenda and any updates will be available at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2013.html or by emailing Ms. Sophie
Holiday at the contact information below.
Purpose: Discuss issues related to 10 CFR part 35 Medical Use of
Byproduct Material.
Date and Time for Closed Sessions: September 09, 2013, from 8:30
a.m. to 10:30 a.m. and September 10, 2013 from 8:30 a.m. to 10:30 a.m.
The first session will be closed for ACMUI training. The second session
will be closed so that ACMUI members can prepare for a Commission
Briefing in October 2013.
Date and Time for Open Sessions: September 09, 2013, from 10:30
a.m. to 5:00 p.m. and September 10, 2013, from 10:30 a.m. to 5:00 p.m.
Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two
White Flint North Building, Room T2-B3, 11545 Rockville Pike,
Rockville, MD 20852.
Public participation: Any member of the public who wishes to
participate in the meeting in person or via phone should contact Ms.
Holiday using the information below. The meeting will also be webcast
live: video.nrc.gov.
CONTACT INFORMATION: Sophie J. Holiday, email: sophie.holiday@nrc.gov,
telephone: (301) 415-7865.
Conduct of the Meeting
Bruce R. Thomadsen, Ph.D., will chair the meeting. Dr. Thomadsen
will conduct the meeting in a manner that will facilitate the orderly
conduct of business. The following procedures apply to public
participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. Holiday at the contact information listed above.
All submittals must be received by September 2, 2013, and must pertain
to the topic on the agenda for the meeting.
2. Questions and comments from members of the public will be
permitted during the meeting, at the discretion of the Chairman.
3. The draft transcript and meeting summary will be available on
ACMUI's Web site https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2013.html on or about October 22, 2013.
4. Persons who require special services, such as those for the
hearing impaired, should notify Ms. Holiday of their planned
attendance.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in Title
10, U.S. Code of Federal Regulations, Part 7.
Dated: July 1, 2013.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2013-16433 Filed 7-9-13; 8:45 am]
BILLING CODE 7590-01-P
